| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |